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Results: There were no signiﬁcant differences in age, sex, blood pressure, heart rate or
LVEF between the AS patients and controls. The LV mass index was dramatically
higher in AS patients than controls (106.327.5 vs. 67.410.5 g/m2, P<0.001).
Comparing with healthy controls, AS patients had signiﬁcantly lower circulating
levels of miR-1 (0.557 (0.202-0.711) vs. 0.979 (0.785-1.242), P<0.001), miR-133
(0.543 (0.469-0.651) vs. 0.947 (0.749-1.436), P<0.001) and miR-378 (0.560 (0.517-
0.736) vs. 0.944 (0.627-1.610), P<0.001). In the AS group, patients with LVH had
signiﬁcantly lower miR-378 (0.539 (0.515-0.629) vs. 0.624 (0.549-0.903), P¼0.022)
but not miR-1 and miR-133 compared with those without LVH. Linear regression
analysis showed circulating miR-378 had strong correlation with left ventricular mass
index (r¼0.283, P¼0.002) and logistic regression showed that lower miR-378 was an
independent predictor for LVH in patients with AS (P¼0.037, OR 4.110, 95% CI
1.086-15.558).
Conclusions: Circulating levels of miR-1, miR-133 and miR-378 were decreased in
AS patients, and miR-378 predicts LVH independent of the pressure gradient. Further
prospective investigations are needed to elucidate whether these circulating miRs
affect clinical outcome.
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Clinical proﬁle and predictors of outcomes of patients with mitral stenosis
undergoing percutaneous transseptal mitral commissurotomy
Edgar Timbol, Jaime Alfonso M. Aherrera, Gino Rei Quizon, Wilfredo Dee
Philippine General Hospital
Objectives: To present the clinical, echocardiographic, and hemodynamic proﬁle of
adult patients with MS who have undergone percutaneous transseptal mitral com-
missurotomy from 2010 to 2013 at the Philippine General Hospital.
Methods: We conducted a retrospective study of all adults with MS who underwent
PTMC from 2010-2013. Data were extracted using a standard data collection form.
A successful PTMC or a favorable outcome is deﬁned as a post- procedural hemo-
dynamic study of a mitral valve area (MVA) >1.5cm2 and/or a mean transmitral
gradient < 5mmHg. Other outcomes measured in this study were the development or
worsening of mitral regurgitation measured by hemodynamic studies, in-hospital
death, and post-procedural 2D echocardiography measurements of MVA > 1.5cm2
and mean mitral gradient <5 mmHg. Simple logistic regression was used to determine
the predictors of an unfavorable outcome after PTMC.
Results: 104 patients with a mean age of 38 years old, predominantly female, were
included. Majority had congestive heart failure functional class II and severe MS with
a mean Wilkin’s score of 7.9 by echocardiography. A successful PTMC was achieved
in 89%. Having a “repeat PTMC” (ie. PTMC for the second time) was associated with
an increased risk of developing an unfavorable outcome or failed PTMC [(OR 7.62,
CI 1.73-33.6)]. Moderate to severe or worsening of prior mitral regurgitation deter-
mined by hemodynamic studies developed in 3%. In-hospital mortality occurred in
3%. Pre- procedural hypotension (BP < 90/60) was associated with increased risk of
developing a new or worsening MR [OR 25.6, CI 1.28-516)] or death [OR 29 (CI
1.74-871)]. An MVA >1.5cm2 was achieved in 77% and 81% of patients measured by
2D echocardiogram and hemodynamic studies, respectively. A mean transmitral
gradient of < 5mmHg was achieved in 60% and 63% measured by 2D echocardio-
gram and hemodynamic studies, respectively.
Conclusions: The typical clinical proﬁle of a patient undergoing PTMC at PGH was a
middle-aged female with minimal co- morbidities, CHF functional class II from severe
MS. We described the clinical proﬁle and predictors of outcomes in patients who have
undergone PTMC in our center. Overall outcomes were excellent, but prospective
studies are recommended to evaluate hard outcomes such as functional capacity and
long-term mortality.
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Inhibitory Effects of Dronedarone on Small Conductance Calcium Activated
Potassium Channels in Patients with Chronic Atrial Fibrillation: Comparison to
Amiodarone
Li Miaoling, Huan Lan, Tao Li, Xianhong Ou, Guilan Chen, Yan Yang,
Xiaorong Zeng
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Luzhou Medical College
Objectives: Small conductance calcium activated potassium channels (SK) were
found closely related to Atrial Fibrillation (AF). Dronedarone is recently used for the
patients with paroxysmal AF or after conversion of persistent AF. The purpose of this
study was to conﬁrm the inhibitory effects of dronedarone on SK as one of the potent
treated targets in patients with AF.
Methods: The right atrial appendages were obtained from 21 patients with sinus rate
(SR) and 18 patients with chronic AF (CAF). Single myocytes were isolated by
enzymatic dissociation with two-step method. The ionic currents were recorded using
whole-cell Conventional patch clamp techniques.
Results: The SK channels in patients atrial were sensitive to intracellular calcium, but
voltage-independent.Similar to amiodarone, dronedarone showed a concentration-
dependent inhibitory manner on SK channels current. In patients with SR, drone-
darone and amiodarone inhibited the SK channel current with IC50 values of 0.23 and
6.37 microM, respectively, which were close to their therapeutic concentrations. In
patients with CAF, the IC50 values were 0.09 microM with dronedarone and 2.1
microM with amiodarone.The inhibitory effects of dronedarone on SK channels wereJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cpotently in CAF than in SR. Compared with amiodarone, dronedarone showed more
effective inhibition on SK channels, especially during in patients with CAF.
Conclusions: Dronedarone exhibits strongly inhibitory effects on SK channels during
in patients with CAF, which might be one of treated targets of dronedarone for the
management of AF.
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The value of echocardiography in transcatheter aortic valve implantation
Wei Xin, Chen Mao, Feng Yuan, Chen Liping, Zhao Zhengang, Tang Hong
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China
Objectives: To investigate the value of the echocardiography in pre-operative,
intraoperative, and postoperative transcatheter aortic valve implantation (TAVI).
Methods: This study included 43 patients (27 males; 16 females; average ages was
747.2 years) with severe aortic valve stenosis who underwent successful TAVI in
our hospital. The anatomy of the aortic valve, aortic annulus, ventricular function and
other concerns were assessed by transthoracic echocardiography (TTE) one week
before TAVI and also by transesophageal echocardiography (TEE) during TAVI.
After the deployment of the prosthesis, TEE was used to ensure the position/stability
of prosthesis, severity and mechanism of aortic regurgitation (AR), and to assess
complications. One week post TAVI, TTE is sufﬁcient to check the prosthesis,
quantify the AR, and evaluate the changes of the ventricular function and left ven-
tricular mass.
Results: The aortic annulus dimension (AAD) measured by RT 3D-TEE was larger
and measured by 2D TEE, with no statistically signiﬁcant difference. But the AAD
measured by TTE was smaller than by RT 3D-TEE and 2D-TEE, with signiﬁcant
difference. None of the patients had cardiac tamponade and aortic dissection during
TAVI. Compared with pre-TAVI, The maximum aortic valve velocity and mean aortic
pressure gradient was decreased signiﬁcantly after TAVI (5.20.5m/s vs.2.70.5 m/s,
6715 mmHg vs.165 mmHg, respectively, P<0.05). The left ventricular ejection
fraction measured by 3D TTE was increased (48.28.7% vs.52.07.5, P<0.05). And
the left ventricular mass was improved (165.547.7 g/m2 vs.144.039.2 g/m2,
P<0.05). No server AR and central AR was observed post-TAVI. 2.3% patients
presented with moderate paravalvular AR, 30.2% patients with mild paravalvular AR,
and 67.5% with trace or no paravalvular AR.
Conclusions: Echocardiography play an important role in pre-operative, intra-
operative, and postoperative TAVI.
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The impact of Klotho protein and FGF23 on degenerative heart valvular disease
Zhang Jianyu, Yu-Li Huang, Liang Su, Ding-Li Xu, Ding-Li Xu
Nanfang Hospital, Southern Medical University
Objectives: This study aimed to evaluate the expression of Klotho protein, Fibroblast
growth factor 23 (FGF23) in degenerated heart valvular disease (DHVD) patients and
their role in valvular calciﬁcation.
Methods: 71 suspected DHVD hospitalized patients (aged 50 years) were enrolled
between August 2012 and April 2013. Patients were divided into with valvular
calciﬁcation (DHVD group) and without valvular calciﬁcation group (non-DHVD
group) according to transthoracic echocardiographic examination. Serum calcium,
phosphorus, iPTH, hs-CRP were detected. Klotho and FGF23 were detected by
ELISA. Patients were followed for death or recurrent hospital admission in 32 weeks.
Results: (1) There were 39 patients with DHVD. Patients in DHVD group were older
than those in non-DHVD group (73.8 vs 69.4 years, P¼0.03) . There were no sig-
niﬁcant differences in coronary heart disease, hypertension, diabetes and smoking
between DHVD group and non-DHVD group (P>0.05) .The levels of hs-CRP (19.06
mg/L vs 5.06 mg/L, P¼0.01) , FGF23 (85.43 pg/ml vs 11.82 pg/ml, P¼0.001) were
higher in DHVD group than that in non-DHVD group and the results were not
changed when stratiﬁed by age or glomerular ﬁltration rate. However, there were no
signiﬁcant differences in the levels of Klotho protein, calcium, phosphorus and iPTH
between DHVD group and non-DHVD group (all P > 0.05). (2) The survival rate
were higher in non-DHVD group than that in DHVD group (100% vs 86.5%,
P¼0.045) . Multivariate Cox regression model was used to analyze the association
between survival and clinical parameter, including age, hs-CRP, Klotho protein,
FGF23, GFR, Lp (a). The levels of hs-CRP, FGF23 were identiﬁed as independent
prognostic factors for survival (RR¼1.033, P¼0.004; RR¼1.007, P¼0.048,
respectively).
Conclusions: The levels of FGF23 and hs-CRP in patients with DHVD were sig-
niﬁcant higher than that in non-DHVD and associated with poor clinical outcome.
FGF23 may be involved in the process of the DHVD, and the mechanisms may be
independent of the FGF23/Klotho axis.
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Objectives: To analyze the prevalence of Calciﬁc Aortic Valve Disease (CAVD) in
the Chinese population.
Methods: Data was collected from Echocardiogram reports of subjects who had been
examined in the Cardiology Department of our hospital spanning a period of eight
years; from January 2005 to December 2012.The data collected was then analyzed
using statistical methods Independent t Test and Chi Square tests of SPSS 13.0 of IBM
SPSS Statistics. The level of signiﬁcance was set at 99% Conﬁdence Interval.
Results: The total number of subjects aged 45 years was (n¼17826), men (n¼9725,
54.6%). The estimated prevalence in our study subjects for individuals 45 years and
older was 12.8% (99% CI, 12.1%-13.4%), the estimated prevalence among men was
13.6% (99%, 12.7%-14.5%) and that among women was 11.9% (99%CI, 11%-
12.8%). The mean age of prevalence for men was (7010) years and for women was
(71 10) years. We observed a dramatic increase of prevalence with advancing age,
the four age groups 45-64, 65-74, 75-84 and 85 years old or older, had the prevalence
of 5.3%, 20.5% 32.9% and 54.4% respectively. For individuals aged 65 years and
older the estimated prevalence was 25.7% approximately equivalent to that estimated
in the western population. At the time of examination, stenosis ranging from mild to
severe had already set in 15% of those with CAVD. Regurgitation of the aortic valves
was the most frequent functional abnormality observed and the most frequent involved
leaﬂet was the noncoronary valve leaﬂet. Hypertension had the closest association
with CAVD, 27% of subjects in the CAVD group were hypertensive. A signiﬁcant
association was also observed between CAVD and CHD.
Conclusions: This study shows that, prevalence of CAVD in the Chinese population
does not differ from that already observed in the Western population, the prevalence of
CAVD showed a signiﬁcant increase as age increases. Hypertension has a closest
association with CAVD; therefore effective control of hypertension may help delay
the onset or control the progression of CAVD.
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Changes of Junctophilin2 in Patients with Chronic Atrial Fibrillation
Li Miaoling, Xian-Hong Ou, Huan Lan, Lu-Zhen Wang, Yan Yang, Xiaorong Zeng
Key laboratory of medical electrophysiology of Ministry of Education, Luzhou
Medical College
Objectives: Junctophilin-2 (JP2) is a membrane-binding protein coupling between
plasma membrane L-type Ca2+ channels and sarcoplasmic reticular ryanodine re-
ceptors (Ryr) in cardiac myocytes which regulate intracellular calcium stability.
Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal
intracellular calcium-handling. The aim of this study was to investigate whether the
changes of JPH2 contributes to the development of atrial ﬁbrillation (AF).
Methods: The mRNA level of JP2 was assayed by quantitative polymerase chain
reaction and the protein level of JP2 was determined using western blot analysis (12
atrial appendages from patients with sinus rhythm (SR) and 24 atrial appendages from
patients with Chronic AF (CAF).
Results: Our results identiﬁed that the JP2 protein was expressed in patients atrial
both in SR and CAF. The mRNA level was down-regulation in Patients atrial with
CAF (n¼24, P<0.01) compared with SR (n¼12). Consistent with the mRNA level,
the protein level of JP2 in CAF (n¼24) was decreased signiﬁcantly (P<0.01) than in
SR (n¼12). Our results showed that JP2 reduced the express in mRNA level and
protein level in patients with CAF.
Conclusions: Reduced levels of JP2 may contribute to excitation-contraction coupling
dysfunction in CAF, which induce abnormal intracellular calcium handling during AF.
Therefore, JP2 maybe as a new therapeutic strategy of patients with Atrial Fibrillation.
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Short Term Clinical Outcomes After Percutaneous Mitral Commissurotomy For
Mitral Stenosis Based On Wilkin’S Score
Muhammad Abdur Rauf, Nida Mahmood, Wahaj Aman, Mohammad Haﬁzullah,
Malik Faisal Iftikhar, Adnan Mehmood Gul
Lady Reading hospital Peshawar Pakistan
Objectives: To determine the frequency of short term clinical outcomes of percuta-
neous transvenous mitral commissurotomy for mitral stenosis among patients having
wilkin score of <12.
Methods: This was a descriptive cross sectional study carried out at Cardiology Unit
Govt. Lady Reading Hospital Peshawar. Duration of study was nine months and
twenty days (July 01, 2012 - June 20, 2013) .Mitral stenosis patients with or without
pre existing mild mitral regurgitation admitted in Cardiology Unit, Lady Reading
Hospital Peshawar were included in the study. After performing PTMC according to
standard protocol, data regarding improvement in mitral valve area, pulmonary artery
pressure and severity of mitral regurgitation was recorded.
Results: Out of total 175 patients 56 (32%) were males. The mean age of the patients
was 22.697.93 years. Mean BMI of patients was 21.073.95. Mean Wilkin’s score
was 6.691.99 ranging from 3-11. Improvement in mitral valve area, pulmonary
artery pressure, mitral valve gradient and left atrial volume were found in 148 (84.6%) ,
170 (97.1%) , 175 (100%) and 170 (97.1%) respectively. While worsening in mitral
regurgitation was 47 (26.9%).
Conclusions: PTMC is a safe and effective procedure with good short term outcomes
like improvement in mitral valve area, pulmonary artery pressure, mitral valve
gradient and left atrial volume and not worsening mitral regurgitations in patients of
mitral stenosis having Wilkin’s score < 12.C196 JACC Vol 64/16/Suppl C j October 16–1Cardiomyopathy
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Outcome of patients with hypertrophic obstructive cardiomyopathy after
modiﬁed Morrow procedure: A single center experience in China
Song Yunhu
National Center For Cardiovascular Disease China, Fu Wai Hospital, Peking Union
Medical College, Chinese Academy of Medical Sciences
Objectives: In 1984, Fu Wai Hospital pioneered the surgical treatment of hypertro-
phic obstructive cardiomyopathy (HOCM) in China. In 2002 we evolved our septal
myectomy technique with wider septal resection to the base of both papillary muscles
without mitral valve leaﬂets treatment. This study was conducted to evaluate follow-
up Results in patients with HOCM who underwent modiﬁed Morrow procedure in
China.
Methods: Between 2002 and 2014, a total of 201 consecutive HOCM patients who
underwent modiﬁed Morrow procedure by the author in Fu Wai Hospital were
retrospectively recruited. The clinical effects were evaluated during the follow-up
period.
Results: Among 201 patients, 142 patients were treated with isolated modiﬁed
Morrow procedure, 59 patients who had other cardiac lesions underwent modiﬁed
Morrow procedure simultaneous associated cardiac procedures, including coronary
artery bypass graft, cardiac valve repair and replacement, repair of congenital heart
disease, radiofrequency ablation for atrial ﬁbrillation, right ventricular outﬂow tract
reconstruction and cardiac tumor resection. None of the patients died during the
operation. Cardiopulmonary bypass time was (85.231.1) minutes and aortic
clamping time was (55.221.2) minutes. The width, length and thickness of excised
septal myocardium were (43.29.3) mm, (44.48.5) mm and (11.02.7) mm,
respectively. After the operation, the left ventricular outﬂow tract (LVOT) pressure
gradient decreased from (92.230.4) mmHg to (16.09.9) mmHg (P<0.001). Mitral
regurgitation was signiﬁcantly improved, and 198 cases were trivial or no regurgita-
tion (P< 0.001). There were 6 (3%) patients received permanent pacemaker im-
plantation because of complete atrial-ventricular block, 3 (1.5%) underwent
concurrent ventricular septal perforation repair, 1 underwent apical anterior wall
perforation repair. 136 patients were followed-up (3 to 141 months) . During this
period, the average LVOT pressure gradient was at (14. 111.8) mmHg. 109 patients
were out of symptoms and were able to engage in daily housework or return to work.
The post-operative NYHA signiﬁcantly improved to (1.20.5) compared with
(2.90.4) preoperatively (P<0.001). HOCM related events were 4% including 4
patients of AF, 2 patients of myocardial ischemia, 1 patient of heart failure (HF), 1
patient of stroke accompanying HF with re-hospitalization. 1 patient died of Stanford
type A aortic dissection rupture 57 months after the operation.
Conclusions: Modiﬁed Morrow procedure across the aortic incision was an effective
treatment for HOCM. To excise thoroughly hypertrophic septal myocardium and
released papillary muscle were the key to improve the efﬁcacy of this operation.
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Frequent Premature Ventricular Complexes Ablation Improves Left Ventricular
Function
Zhang Tuo, Zang Minhua, Mao Jialiang, He Ben
Department of Cardiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong
University
Objectives: Frequent premature ventricular complexes (PVCs) are associated with
left ventricular (LV) dysfunction. We performed a meta-analysis to evaluate the
effects of catheter ablation on improvement of LV function in patients with
frequent PVCs.
Methods: We searched MEDLINE for cohort studies of patients who underwent
catheter ablation of frequent PVCs. LV ejection fraction (LVEF) both before and
post-ablation was reported. The endpoints were changes from baseline in LVEF post-
ablation. Subgroup analysis of patients with LV dysfunction at baseline was
performed. Quantitative analysis of continuous variables was performed according to
random-effect Methods by MetaAnalyst Beta3.13 software. A 5% absolute increase
borderline in LVEF post-ablation for clinically signiﬁcance was prespeciﬁed. If the
lower limit of 95%CI of the overall mean change in LVEF post-ablation was beyond
the prespeciﬁed borderline, the effect of PVC ablation on LV function improvement
would be considered clinically signiﬁcant by 1-tailed student t test (0.05).
Results: Fifteen studies with 712 patients were included. The mean PVC burden
before catheter ablation was 24% [95% conﬁdence intervals (CIs): 19%–29%]. The
long-term success rate of PVC ablation ranged from 66%–90%. The overall mean
increase from baseline in LVEF post-ablation was 7.7% (95%CI: 6.1%–9.4%). The
student’s t test showed that the overall mean change in LVEF was beyond the
borderline of signiﬁcance (t value ¼ 3.23, p<0.05, Figure A). Subgroup analysis
showed that the overall mean increase from baseline in LVEF post-ablation was
12.4% (95%CI: 8.1%–16.6%) in patients with LV dysfunction at baseline. The stu-
dent’s t test showed that the overall mean change of LVEF in patients with LV
dysfunction at baseline was beyond the borderline of signiﬁcance (t value ¼ 3.44,
p<0.05, Figure B).9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
